Back to top

earnings: Archive

Zacks Equity Research

CVS Health (CVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CVSNegative Net Change

Zacks Equity Research

Dine Brands (DIN) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Dine Brands (DIN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

DINNegative Net Change

Zacks Equity Research

SpaceX Beats Q2 Earnings Estimates on AI Cloud and Starlink Growth

SPCX beats Q2 estimates as revenue surged 91.9%, fueled by AI cloud deals and Starlink growth, while heavy capex reshaped cash deployment.

SPCXPositive Net Change ADIPositive Net Change AMATNegative Net Change KEYSPositive Net Change

Zacks Equity Research

Unlocking FMC (FMC) International Revenues: Trends, Surprises, and Prospects

Evaluate FMC's (FMC) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

FMCNegative Net Change

Zacks Equity Research

Curious about Reinsurance Group (RGA) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Reinsurance Group (RGA) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

RGAPositive Net Change

Zacks Equity Research

Unveiling Maplebear (CART) Q2 Outlook: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Maplebear (CART), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

CARTNegative Net Change

Zacks Equity Research

Unlocking Q2 Potential of Globus Medical (GMED): Exploring Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

GMEDNegative Net Change

Zacks Equity Research

Countdown to Axsome (AXSM) Q2 Earnings: Wall Street Forecasts for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Axsome (AXSM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

AXSMNegative Net Change

Zacks Equity Research

Alcon (ALC) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Alcon (ALC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

ALCNegative Net Change

Zacks Equity Research

Insights Into Consolidated Water (CWCO) Q2: Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Consolidated Water (CWCO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

CWCOPositive Net Change